Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2014-08-05
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the best dosage of Capecitabine and Tarceva
combination in the setting of radiation and to assess treatment effectiveness,
progression-free survival and overall survival.
Phase:
Phase 1
Details
Lead Sponsor:
Milton S. Hershey Medical Center Penn State University